Navigation Links
Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares.
Date:10/21/2008

nges in pricing and the competitive environment, (2) fluctuations in foreign currency exchange rates, (3) dependence on uninterrupted manufacturing operations, (4) changes in the regulatory environment in which the Company operates, (5) changes in worldwide tax rates or tax benefits from domestic and international operations, including the matters described in Note 4- Uncertainty in Income Taxes- to the Consolidated Financial Statements in the Company's Form 10-Q report for the quarter ended June 30, 2008, (6) exposure to litigation, including product liability claims, (7) changes in research funding and the success of research and development activities, (8) the ability to maintain adequate quality standards, (9) reliance on third party package delivery services, (10) the impact of acquisitions and success in integrating and obtaining projected results from the acquisitions, (11) other changes in the business environment in which the Company operates, and (12) the outcome of the matters described in Note 13 - Contingent Liabilities and Commitments - to the Consolidated Financial Statements in the Company's Form 10-Q report for the quarter ended June 30, 2008. A further discussion of the Company's risk factors can be found in Item 1A of the Company's Form 10-K report for the year ended December 31, 2007. The Company does not undertake any obligation to update these forward- looking statements.

SIGMA-ALDRICH CORPORATION

Consolidated Statements of Income (Unaudited)

(in millions except per share amounts)

Three Months Ended Nine Months Ended

September 30, September 30,

2008 2007 2008 2007

Net sales $540.6 $503.2 $1,690.9 $1,506.6

Cost of products sold 262.7 247.3 825.9
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Sigma-Aldrich Welcomes Memorial Sloan-Kettering Cancer Center to the RNAi Partnership Program
2. Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement
3. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in Peer-Reviewed Video Journal JoVE
4. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMeds Peer-Reviewed Video Journal JoVE
5. Sigma-Aldrich to Present at the UBS 2008 Global Life Sciences Conference on September 24, 2008
6. Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
7. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
8. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
9. Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72.
10. Sigma-Aldrich Corporations 2nd Quarter 2008 Earnings Conference Call
11. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015 Immune Pharmaceuticals Inc., or "Immune" ... Directors has elected Rene-Pierre Azria as a ... Committee, with oversight on strategic and financial transactions. Mr. ... Committee, the Compensation Committee and the Corporate Governance and ... commented: "I have a long-time interest in Life Sciences ...
(Date:4/21/2015)... , April 21, 2015  Novogen Limited (ASX:NRT; ... biotechnology company, advises that it has entered into ... fully-paid ordinary shares plus one attaching 6-month option ... every ordinary share issued, to institutional investors in ... a private placement for aggregate gross proceeds of ...
(Date:4/21/2015)... April 21, 2015 Leading-edge ... clinical applications will be presented at the ... scientists, regulators and clinicians from academia, industry ... sponsored by Invibio Biomaterial Solutions. The world-leading ... specialist in manufacturing and R&D for medical-device ...
(Date:4/20/2015)... April 20, 2015 Stent retriever thrombectomy, ... vessels in the brain reduced disability after stroke, ... Jovin, MD, President of the Society of Vascular ... is a giant step forward that will change ... stroke patients," said Jovin, who is associate professor ...
Breaking Biology Technology:Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 2Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 3Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 4Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 2Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 3Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 4Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 5Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 62nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 22nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 3SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 2SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 3
... CV Therapeutics,Inc. (Nasdaq: CVTX ) today announced ... results for 2007 after the market closes on Tuesday,February ... at,5:00 p.m. EST, 2:00 p.m. PST, on the company,s ... on to the Company,s website at, http://www.cvt.com and ...
... In a letter to,Governor Jennifer Granholm today, ... Governor,s State of the State Address,wherein she called ... is the,statewide association for Michigan,s life sciences industry., ... the legislature, to diversify,the state,s economy by focusing ...
... Md., Jan. 30 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: ... commercializing novel anti-infective products, today,announced that it has ... and warrants, resulting in the receipt of $21 ... use the proceeds from the financing to support,the ...
Cached Biology Technology:CV Therapeutics to Announce 2007 Fourth Quarter and Year End Financial Results on Tuesday, February 26, 2008 2MichBio Responds to Governor's Plan to Repeal Tort Reform Laws 2MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million 2MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million 3
(Date:4/14/2015)... April 14, 2015  HYPR Corp. today announced ... ® ) Alliance tm , an industry consortium ... commit to share technology and collaborate to deliver ... interoperable, more secure and private, and easier to ... verification that protects sensitive user information and eliminates ...
(Date:4/10/2015)... , April 10, 2015 Research ... of the "Security Competitive Profiles - NEC" ... , NEC will continue to supply a ... the market, with a company focus on the development ... Winning opportunities in the Asia-Pacific ...
(Date:4/2/2015)... , April 2, 2015 ... DERMALOG by far outperforms the strongest competitors, showing ... high accuracy, the system is capable of a ... speed proves up to be ten times faster ... its runner-up performance.      (Photo: ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3NEC Security Competitive Profile 2015 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... that acts as a "master switch" in certain white ... The study, published in the journal Nature Immunology ... diseases such as rheumatoid arthritis that involve excessive inflammation. ... body uses against harmful stimuli such as infections or ...
... WASHINGTON, Jan. 15, 2011 In research described as "a ... reporting that cigarette smoke begins to cause genetic damage within ... Their report, the first human study to detail the ... cancer, appears in Chemical Research in Toxicology , one ...
... 2010) The kidney is made up of roughly 1 ... waste products from the blood, recycle some substances to be ... segment of nephrons, called the distal nephron, helps set blood ... Today scientists at The University of Texas Health ...
Cached Biology News:Scientists find the 'master switch' for key immune cells in inflammatory diseases 2'A stark warning:' Smoking causes genetic damage within minutes after inhaling 2
...
...
...
... This antibody recognizes murine IRF7 ... with other related IRF proteins. ... murine IRF7 protein was confirmed ... the 293T cells transfected with ...
Biology Products: